Amyvid [package insert]. European Union. Eli Lilly & Co.; 2013.Balasa M, Gelpi E, Antonell A, et al; for the Neurological Tissue Bank/ University of Barcelona/Hospital Clínic NTB/UB/HC Collaborative Group. Clinical features and APOE genotype of pathologically proven early-onset Alzheimer disease. Neurology. 2011;76(20):1720–1725.
Amyvid™ (Florbetapir F 18 Injection) Approved In European Union For Use In Patients With Cognitive Impairment Being Evaluated For Alzheimer's Disease And Other Causes Of Cognitive Impairment
Check Out Our Best Services for Investors
- $2.5+ million portfolio
- Large-cap and dividend focus
- Intraday trade alerts from Cramer
Access the tool that DOMINATES the Russell 2000 and the S&P 500.
- Buy, hold, or sell recommendations for over 4,300 stocks
- Unlimited research reports on your favorite stocks
- A custom stock screener
- Model portfolio
- Stocks trading below $10
- Intraday trade alerts